Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charu Aggarwal

Showing results (81-90 of 170) with videos related to

Pageof 17
Sort By:
JAMA Oncology|February 21, 2020
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled TrialSalma K Jabbour, Abigail T Berman, Roy H Decker, et al.
JNCI Cancer Spectrum|January 30, 2025
A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancerNickolas Stabellini, Omar M Makram, Harikrishnan Hyma Kunhiraman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
A phase I dose-escalation study of danusertib (PHA-739358) administered as a 24-hour infusion with and without granulocyte colony-stimulating factor in a 14-day cycle in patients with advanced solid tumorsRoger B Cohen, Suzanne F Jones, Charu Aggarwal, et al.
JCO Precision Oncology|August 21, 2019
Impact of <i>KRAS</i> and <i>TP53</i> Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With <i>STK11</i>-Mutated Advanced Non-Small-Cell Lung CancerErin Bange, Melina E Marmarelis, Wei-Ting Hwang, et al.
JTO Clinical and Research Reports|August 11, 2025
Late Immune-Related Adverse Events After At Least Two Years of Immune Checkpoint Inhibitor Therapy: Incidence and Association With Survival in Patients With Advanced NSCLCOmar Elghawy, Adam Barsouk, Jonathan H Sussman, et al.
Investigational New Drugs|May 22, 2018
Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumorsA Craig Lockhart, Todd M Bauer, Charu Aggarwal, et al.
The Journal of Liquid Biopsy|April 20, 2026
Harmonizing definitions in liquid biopsy: A terminology framework by the international society of liquid biopsyEloísa Jantus-Lewintre, Silvia Calabuig-Fariñas, David Gandara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesotheliomaDaniel E Schwed Lustgarten, Charuhas Deshpande, Charu Aggarwal, et al.
International Journal of Radiation Oncology, Biology, Physics|March 4, 2021
Multiblock Discriminant Analysis of Integrative <sup>18</sup>F-FDG-PET/CT Radiomics for Predicting Circulating Tumor Cells in Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation TherapySang Ho Lee, Gary D Kao, Steven J Feigenberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2019
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)Corey J Langer, Mary W Redman, James L Wade, et al.
Pageof 17

Showing results (81-90 of 170) with videos related to

Sort By:
Pageof 17
JAMA Oncology|February 21, 2020
Phase 1 Trial of Pembrolizumab Administered Concurrently With Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Nonrandomized Controlled TrialSalma K Jabbour, Abigail T Berman, Roy H Decker, et al.
JNCI Cancer Spectrum|January 30, 2025
A novel machine learning-based cancer-specific cardiovascular disease risk score among patients with breast, colorectal, or lung cancerNickolas Stabellini, Omar M Makram, Harikrishnan Hyma Kunhiraman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 15, 2009
A phase I dose-escalation study of danusertib (PHA-739358) administered as a 24-hour infusion with and without granulocyte colony-stimulating factor in a 14-day cycle in patients with advanced solid tumorsRoger B Cohen, Suzanne F Jones, Charu Aggarwal, et al.
JCO Precision Oncology|August 21, 2019
Impact of <i>KRAS</i> and <i>TP53</i> Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With <i>STK11</i>-Mutated Advanced Non-Small-Cell Lung CancerErin Bange, Melina E Marmarelis, Wei-Ting Hwang, et al.
JTO Clinical and Research Reports|August 11, 2025
Late Immune-Related Adverse Events After At Least Two Years of Immune Checkpoint Inhibitor Therapy: Incidence and Association With Survival in Patients With Advanced NSCLCOmar Elghawy, Adam Barsouk, Jonathan H Sussman, et al.
Investigational New Drugs|May 22, 2018
Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumorsA Craig Lockhart, Todd M Bauer, Charu Aggarwal, et al.
The Journal of Liquid Biopsy|April 20, 2026
Harmonizing definitions in liquid biopsy: A terminology framework by the international society of liquid biopsyEloísa Jantus-Lewintre, Silvia Calabuig-Fariñas, David Gandara, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 15, 2013
Thymidylate synthase and folyl-polyglutamate synthase are not clinically useful markers of response to pemetrexed in patients with malignant pleural mesotheliomaDaniel E Schwed Lustgarten, Charuhas Deshpande, Charu Aggarwal, et al.
International Journal of Radiation Oncology, Biology, Physics|March 4, 2021
Multiblock Discriminant Analysis of Integrative <sup>18</sup>F-FDG-PET/CT Radiomics for Predicting Circulating Tumor Cells in Early-Stage Non-small Cell Lung Cancer Treated With Stereotactic Body Radiation TherapySang Ho Lee, Gary D Kao, Steven J Feigenberg, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2019
SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study)Corey J Langer, Mary W Redman, James L Wade, et al.
Pageof 17